TuHURA Biosciences (HURA) Operating Expenses (2010 - 2026)

TuHURA Biosciences' Operating Expenses history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 7.31% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $32.3 million, a 43.02% increase from a year earlier, with the FY2025 full-year figure at $31.8 million, up 80.15% from the prior year.
• Operating Expenses retreated to $7.5 million in Q1 2026 per HURA's latest filing, from $8.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $12.0 million in Q3 2024 and bottomed at -$2.4 million in Q2 2023.
• The 5-year median for Operating Expenses is $5.4 million (2022), against an average of $5.5 million.
• Across the five-year window, Operating Expenses soared 303.6% in 2024 and slumped 43.71% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $3.5 million in 2022, then climbed by 13.78% to $4.0 million in 2023, then surged by 200.29% to $12.0 million in 2024, then sank by 31.63% to $8.2 million in 2025, then decreased by 7.87% to $7.5 million in 2026.
• Per Business Quant, the three latest HURA Operating Expenses figures stand at $7.5 million (Q1 2026), $8.2 million (Q4 2025), and $6.7 million (Q3 2025).